Table 2. Surgical characteristics of patients in nICT and nICRT groups.
| Characteristics | nICT (n=37)† | nICRT (n=17) | P value |
|---|---|---|---|
| Surgery time (min), median | 289 | 262 | 0.27 |
| Blood loss (mL), median | 100 | 100 | 0.65 |
| Operative approaches, n (%) | 0.99 | ||
| MeKeown | 35 (94.6) | 17 (100.0) | |
| Ivor-Lewis | 2 (5.4) | 0 | |
| Minimally invasive technique, n (%) | 0.35 | ||
| MIE | 28 (75.7) | 11 (64.7) | |
| HMIE | 5 (13.5) | 5 (29.4) | |
| OE | 4 (10.8) | 1 (5.9) | |
| Lymph nodes removed, n | 23 | 16 | 0.05 |
| pCR, n (%) | 8 (21.6) | 7 (41.2) | 0.19 |
| Primary tumor pCR, n (%) | 8 (21.6) | 9 (52.9) | 0.03* |
| Length of hospital stay (days) | 11 | 14 | 0.16 |
| 30-day mortality, n (%) | 0 | 1 (5.9) | 0.31 |
†, one patient in the nICT group underwent open-close surgery, with no resection, so it is not included in the postoperative analysis; *, P<0.05. nICT, neoadjuvant immunotherapy combined with chemotherapy; nICRT, neoadjuvant immunotherapy combined with chemoradiotherapy; MIE, minimally invasive esophagectomy; HMIE, hybrid minimally invasive esophagectomy; OE, open esophagectomy; pCR, pathological complete response.